Annexin Pharmaceuticals (Sweden) Pattern Recognition Rising and Falling Three Methods

ANNX Stock  SEK 14.70  0.20  1.38%   
The pattern recognition view organizes Rising and Falling Three Methods recognition and supporting indicators around Annexin Pharmaceuticals. The analysis highlights pattern recognition signals tied to momentum and continuation and frames technical signals with volatility and risk context.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Rising/Falling Three Methods may indicate that Annexin Pharmaceuticals has been in a downtrend and is about to experience bullish continuation signal

Annexin Pharmaceuticals Technical Analysis Modules

Most technical analysis of Annexin Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Annexin from various momentum indicators to cycle indicators. When you analyze Annexin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden. Downside history and drawdown behavior provide context for risk expectations in Annexin Pharmaceuticals. Past price movements indicate comparatively limited downside dispersion. Annexin Pharmaceuticals has a market cap of 189.95 M, ROE of -105.95%.

Methodology

Unless otherwise specified, financial data for Annexin Pharmaceuticals AB is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Annexin (SE:ANNX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Annexin Pharmaceuticals AB may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Annexin Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
FinTech Idea
FinTech
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Momentum Idea
Momentum
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 20 shares

Additional Tools for Annexin Stock Analysis

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets